MOCLOBEMIDE-AS moclobemide 150 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

moclobemide-as moclobemide 150 mg film-coated tablet blister pack

medis pharma pty ltd - moclobemide, quantity: 150 mg - tablet, film coated - excipient ingredients: pregelatinised maize starch; lactose monohydrate; sodium starch glycollate; povidone; magnesium stearate; hypromellose; peg-8 stearate; microcrystalline cellulose; propylene glycol; titanium dioxide; iron oxide yellow - treatment of major depression.

MOCLOBEMIDE ACTAVIS moclobemide 300 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

moclobemide actavis moclobemide 300 mg film-coated tablet blister pack

medis pharma pty ltd - moclobemide, quantity: 300 mg - tablet, film coated - excipient ingredients: hypromellose; sodium starch glycollate; propylene glycol; titanium dioxide; microcrystalline cellulose; magnesium stearate; povidone; lactose monohydrate; pregelatinised maize starch; peg-8 stearate - treatment of major depression.

MOCLOBEMIDE ACTAVIS  moclobemide 150 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

moclobemide actavis moclobemide 150 mg film-coated tablet blister pack

medis pharma pty ltd - moclobemide, quantity: 150 mg - tablet, film coated - excipient ingredients: propylene glycol; microcrystalline cellulose; magnesium stearate; iron oxide yellow; sodium starch glycollate; hypromellose; lactose monohydrate; pregelatinised maize starch; povidone; titanium dioxide; peg-8 stearate - treatment of major depression.

Apo-Moclobemide New Zealand - English - Medsafe (Medicines Safety Authority)

apo-moclobemide

apotex nz ltd - moclobemide 150mg; moclobemide 150mg - film coated tablet - 150 mg - active: moclobemide 150mg excipient: carnauba wax colloidal silicon dioxide croscarmellose sodium dextrates hypromellose iron oxide yellow macrogol 3350 magnesium stearate polydextrose titanium dioxide active: moclobemide 150mg excipient: carnauba wax colloidal silicon dioxide croscarmellose sodium dextrates hypromellose iron oxide yellow macrogol 3350 magnesium stearate polydextrose titanium dioxide - apo-moclobemide is indicated in the treatment of depressive syndromes and social phobia.

RATIO-MOCLOBEMIDE - TAB 150MG TABLET Canada - English - Health Canada

ratio-moclobemide - tab 150mg tablet

ratiopharm inc division of teva canada limited - moclobemide - tablet - 150mg - moclobemide 150mg - monoamine oxidase inhibitors

NU-MOCLOBEMIDE TABLET Canada - English - Health Canada

nu-moclobemide tablet

nu-pharm inc - moclobemide - tablet - 100mg - moclobemide 100mg - monoamine oxidase inhibitors

NU-MOCLOBEMIDE TABLET Canada - English - Health Canada

nu-moclobemide tablet

nu-pharm inc - moclobemide - tablet - 150mg - moclobemide 150mg - monoamine oxidase inhibitors

RIVA-MOCLOBEMIDE 150MG TABLETS Canada - English - Health Canada

riva-moclobemide 150mg tablets

laboratoire riva inc. - moclobemide - tablet - 150mg - moclobemide 150mg - monoamine oxidase inhibitors

Adco-Moclobemide 300 mg Namibia - English - Namibia Medicines Regulatory Council

adco-moclobemide 300 mg

adcock ingram limited - moclobemide - tablets - each tablet contains moclobemide 300 mg

MOCLOBEMIDE-STR moclobemide 300 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

moclobemide-str moclobemide 300 mg film-coated tablet blister pack

gm pharma international pty ltd - moclobemide, quantity: 300 mg - tablet, film coated - excipient ingredients: pregelatinised maize starch; lactose monohydrate; sodium starch glycollate; povidone; magnesium stearate; hypromellose; microcrystalline cellulose; peg-8 stearate; titanium dioxide; propylene glycol; purified water - treatment of major depression.